CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 21.7
(0.37%)
EUR 21.7
(0.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 45.91 Million EUR | -37.45% |
| 2022 | 73.41 Million EUR | 6.44% |
| 2021 | 68.97 Million EUR | -5.77% |
| 2020 | 73.19 Million EUR | 11.2% |
| 2019 | 65.81 Million EUR | -28.72% |
| 2018 | 92.33 Million EUR | 195.48% |
| 2017 | 31.25 Million EUR | -29.82% |
| 2016 | 44.53 Million EUR | 15.68% |
| 2015 | 38.49 Million EUR | 46.16% |
| 2014 | 26.33 Million EUR | 13.78% |
| 2013 | 23.14 Million EUR | -24.64% |
| 2012 | 30.71 Million EUR | 231.31% |
| 2011 | 9.27 Million EUR | -44.13% |
| 2010 | 16.59 Million EUR | 41.63% |
| 2009 | 11.71 Million EUR | 823.97% |
| 2008 | 1.26 Million EUR | -94.49% |
| 2007 | 23.03 Million EUR | 294.09% |
| 2006 | 5.84 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 18.51 Million EUR | 216.44% |
| 2024 Q2 | 13.92 Million EUR | -24.79% |
| 2023 Q1 | 14.38 Million EUR | 4.21% |
| 2023 FY | 45.91 Million EUR | -37.45% |
| 2023 Q4 | -15.9 Million EUR | -199.72% |
| 2023 Q3 | 15.94 Million EUR | -49.36% |
| 2023 Q2 | 31.49 Million EUR | 118.99% |
| 2022 Q2 | 12.06 Million EUR | -33.74% |
| 2022 Q3 | 29.33 Million EUR | 143.14% |
| 2022 Q1 | 18.2 Million EUR | 46.43% |
| 2022 FY | 73.41 Million EUR | 6.44% |
| 2022 Q4 | 13.79 Million EUR | -52.96% |
| 2021 Q2 | 17.16 Million EUR | 56.38% |
| 2021 Q3 | 28.39 Million EUR | 65.45% |
| 2021 Q4 | 12.43 Million EUR | -56.21% |
| 2021 FY | 68.97 Million EUR | -5.77% |
| 2021 Q1 | 10.97 Million EUR | 16.72% |
| 2020 FY | 73.19 Million EUR | 11.2% |
| 2020 Q4 | 9.4 Million EUR | -72.96% |
| 2020 Q3 | 34.77 Million EUR | 113.06% |
| 2020 Q2 | 16.32 Million EUR | 28.6% |
| 2020 Q1 | 12.69 Million EUR | -5.18% |
| 2019 Q1 | 23.56 Million EUR | -25.69% |
| 2019 Q3 | 18.06 Million EUR | 29.26% |
| 2019 Q4 | 13.38 Million EUR | -25.88% |
| 2019 Q2 | 13.97 Million EUR | -40.7% |
| 2019 FY | 65.81 Million EUR | -28.72% |
| 2018 Q1 | 16.88 Million EUR | 465.16% |
| 2018 Q4 | 31.71 Million EUR | 71.48% |
| 2018 Q3 | 18.49 Million EUR | -26.74% |
| 2018 Q2 | 25.24 Million EUR | 49.49% |
| 2018 FY | 92.33 Million EUR | 195.48% |
| 2017 Q2 | 11.65 Million EUR | -6.48% |
| 2017 FY | 31.25 Million EUR | -29.82% |
| 2017 Q4 | 2.98 Million EUR | -27.84% |
| 2017 Q3 | 4.14 Million EUR | -64.48% |
| 2017 Q1 | 12.46 Million EUR | -0.14% |
| 2016 Q2 | 12.62 Million EUR | 28.87% |
| 2016 Q4 | 12.48 Million EUR | 29.72% |
| 2016 FY | 44.53 Million EUR | 15.68% |
| 2016 Q3 | 9.62 Million EUR | -23.79% |
| 2016 Q1 | 9.79 Million EUR | 14.74% |
| 2015 Q2 | 4.06 Million EUR | -80.56% |
| 2015 Q3 | 4.98 Million EUR | 22.77% |
| 2015 FY | 38.49 Million EUR | 46.16% |
| 2015 Q1 | 20.9 Million EUR | 404.81% |
| 2015 Q4 | 8.53 Million EUR | 71.19% |
| 2014 Q1 | 4.72 Million EUR | -19.68% |
| 2014 Q4 | 4.14 Million EUR | -61.84% |
| 2014 FY | 26.33 Million EUR | 13.78% |
| 2014 Q2 | 6.61 Million EUR | 39.96% |
| 2014 Q3 | 10.85 Million EUR | 64.04% |
| 2013 FY | 23.14 Million EUR | -24.64% |
| 2013 Q4 | 5.88 Million EUR | 4.85% |
| 2013 Q1 | 10.32 Million EUR | 143.64% |
| 2013 Q3 | 5.61 Million EUR | 323.3% |
| 2013 Q2 | 1.32 Million EUR | -87.15% |
| 2012 Q2 | 12.85 Million EUR | 59.67% |
| 2012 Q1 | 8.05 Million EUR | 73.39% |
| 2012 Q3 | 5.57 Million EUR | -56.68% |
| 2012 Q4 | 4.23 Million EUR | -23.93% |
| 2012 FY | 30.71 Million EUR | 231.31% |
| 2011 Q2 | -1.45 Million EUR | -241.56% |
| 2011 Q4 | 4.64 Million EUR | -8.09% |
| 2011 FY | 9.27 Million EUR | -44.13% |
| 2011 Q3 | 5.05 Million EUR | 448.24% |
| 2011 Q1 | 1.02 Million EUR | -81.23% |
| 2010 Q2 | 4.03 Million EUR | 167.51% |
| 2010 FY | 16.59 Million EUR | 41.63% |
| 2010 Q1 | 1.5 Million EUR | -40.02% |
| 2010 Q4 | 5.46 Million EUR | -2.34% |
| 2010 Q3 | 5.59 Million EUR | 38.6% |
| 2009 Q3 | 5.43 Million EUR | 158.96% |
| 2009 FY | 11.71 Million EUR | 823.97% |
| 2009 Q1 | 1.67 Million EUR | 0.0% |
| 2009 Q4 | 2.51 Million EUR | -53.73% |
| 2009 Q2 | 2.09 Million EUR | 25.55% |
| 2008 FY | 1.26 Million EUR | -94.49% |
| 2007 FY | 23.03 Million EUR | 294.09% |
| 2006 FY | 5.84 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| DocCheck AG | 2.27 Million EUR | -1921.426% |
| MeVis Medical Solutions AG | 4.91 Million EUR | -833.338% |
| Nexus AG | 24.03 Million EUR | -91.07% |